Publizoom

Award notice Supplies

Dasatinib

Notice published in French. The AI analysis summarises it for you in your language.

Public buyer
Cliniques universitaires Saint Luc
Woluwe-Saint-Lambert
Place of performance
1200 Woluwe-Saint-Lambert, Brussels-Capital
not published: buyer's address
Bids received
2
Form
Framework agreement
Multi-year contract: the buyer places orders as needs arise.
Procedure
Open procedure
Any company may submit a bid.
Publication
20 March 2024
Notice language
French

AI analysis: go for it or not?

Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.

Create my free account

Unlimited analyses during the 14-day Pro trial, no card needed.

Description

Le marché concerne les fournitures de la spécialité pharmaceutique contenant le principe actif « Dasatinib » en comprimés de 20mg, 50mg, 70mg et 100mg.

Awarded to

CPV codes

European codes that classify what the contract is about. They are how we find the tenders for your trade.

33600000

Winning prices for comparable contracts

A quarter below
€269,390
Median
€449,863
A quarter above
€962,736

Amounts awarded (excl. VAT) over the last 3 years for 58 contracts in the same CPV group (3360…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.

Similar contracts already awarded

ContractWinnerAmount
Trabectédine
Cliniques universitaires Saint Luc · 4 March 2024
PHARMA MAR –
Lénalidomide
Cliniques universitaires Saint Luc · 24 January 2024
Viatris BV SRL –
Darbépoétine Alfa
Cliniques universitaires Saint Luc · 8 January 2024
s.a. Amgen n.v. –
Raamovereenkomst: aankoop CPT intra-vitreale injectie
vzw Jessa Ziekenhuis · 22 October 2026
DE CEUNYNCK MEDICAL €604,000
Leveren van orale antibiotica
UZ Leuven · 16 October 2026
Pfizer
Viatris
Arega Pharma
EUMEDICA
€1,032,354

Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 167612-2024.